Methyl 3-(2-formyl-1H-pyrrol-1-yl)benzoate

Catalog No.: 
ACKIME307
CAS No.: 
168618-86-8
Molecular Formula: 
C13H11NO3
Molecular Weight: 
229.24
Methyl 3-(2-formyl-1H-pyrrol-1-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$116.00InquiryInquiry
1g97%$371.00InquiryInquiry
5g97%$1818.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(2-formyl-1H-pyrrol-1-yl)benzoate
IUPAC Namemethyl 3-(2-formyl-1H-pyrrol-1-yl)benzoate
Molecular FormulaC13H11NO3
Molecular Weight229.24
SMILESO=C(OC)C1=CC=CC(N2C(C=O)=CC=C2)=C1
InChI KeyZEDIMIWDNJGXIL-UHFFFAOYSA-N
Synonymmethyl 3-(2-formyl-1H-pyrrol-1-yl)benzoate;3-(2-FORMYL-1H-PYRROL-1-YL)-BENZOIC ACID METHYL ESTER;BENZOIC ACID, 3-(2-FORMYL-1H-PYRROL-1-YL)-, METHYL ESTER
CAS No.168618-86-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKIME307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBLAR586 route compound structure diagram
    ACBLAR58699769-19-4In Stock
  2. Plus
  3. ACEJBA068 route compound structure diagram
    ACEJBA0681003-29-8In Stock
  4. Then
  5. ACKIME307 route product structure diagram
    ACKIME307168618-86-8
Inquiry

2. ACKIME307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKIME307 route product structure diagram
    ACKIME307168618-86-8
Inquiry

3. ACKIME307 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKIME307 route product structure diagram
    ACKIME307168618-86-8
Inquiry

Comments (0)